Abstract
Middle East respiratory syndrome (MERS) cases continue to be reported from the Middle East. Evaluation and testing of patients under investigation (PUIs) for MERS are recommended. In 2013–2014, two imported cases were detected among 490 US PUIs. Continued awareness is needed for early case detection and implementation of infection control measures.
Highlights
Middle East respiratory syndrome (MERS) cases continue to be reported from the Middle East
To inform state and local health departments of the basic demographic and clinical characteristics of patients under investigation (PUIs) and on assay use, we summarized the descriptive analysis of PUIs in the United States
488 PUIs tested negative for MERS-CoV by rRT-PCR, serologic assay, or both
Summary
Middle East respiratory syndrome (MERS) cases continue to be reported from the Middle East. CDC recommends evaluating and testing PUIs for MERS-CoV and for other common respiratory pathogens. On January 1, 2013, CDC began collecting data on PUIs for MERS-CoV infection.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
